Sunita Goyal

Sunita Goyal, M.D. has a diverse work experience in the medical field. Sunita currently holds the position of Senior Vice President Clinical Development at Beam Therapeutics, starting in July 2021. Prior to this, they worked at bluebird bio as the VP of Clinical Development from November 2018 to June 2021. Sunita also served as the Senior Medical Director of Clinical Development at Alnylam Pharmaceuticals from September 2016 to November 2018. Sunita held multiple roles at Shire Pharmaceuticals, including Senior Medical Director and Medical Director of Clinical Development, from May 2013 to August 2016. Sunita's earlier experiences include working as a Medical Director at Genzyme, Clinical Instructor in Nephrology at Yale University School of Medicine, and an Independent Medical Writer at their own firm, Sunita Goyal, MD, LLC. Sunita began their career as a Research Scientist at Yale University School of Medicine in July 2001.

Sunita Goyal, M.D. completed their Bachelor's degree at Cornell University from 1985 to 1989. Sunita then went on to obtain their MD from UMass Chan Medical School, graduating in 1993. After completing their MD, they joined Yale University School of Medicine for their Internal Medicine Residency Program from 1993 to 1996. Following this, they served as Chief Resident in Internal Medicine at Yale University School of Medicine from 1996 to 1997. In 1997, they pursued a Clinical Nephrology Fellowship at Yale University School of Medicine, which they completed in 1998. Lastly, they worked as a Postdoctoral Research Fellow at Yale University School of Medicine from 1998 to 2001.